PRLD vs SO · rev $6.5M vs P/E 22, rev $29.55B
Prelude Therapeutics Inc (PRLD) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
PRLD currently screens at market cap $346.5M. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the PRLD and SO stock pages for the full models.
Not investment advice.